Equities research analysts at Leerink Partners assumed coverage on shares of Elanco Animal Health (NYSE:ELAN – Get Free ...

As a result of the news, Elanco's stock price declined over 21%, from $17.97 per share on June 26, 2024 to $14.27 per share on June 27, 2024. BFA Law is investigating whether Elanco and certain of its ...

The controversy erupted on June 26, 2024, when Elanco revealed that Zenrelia's label would include a boxed warning, highlighting safety issues identified during trials with unvaccinated dogs. The ...

Faces Securities Class Action Lawsuit Over Alleged Safety Risks of Zenrelia, December 6th Deadline Pending - Hagens Berman ...

We recently published a list of 12 Most Profitable Pharmaceutical Stocks Right Now. In this article, we are going to take a ...

Fintel reports that on December 2, 2024, Leerink Partners initiated coverage of Elanco Animal Health (NYSE:ELAN) with a ...

Elanco Animal Health Incorporated (NYSE: ELAN) today announced that management will participate in upcoming investor ...

Class Action Lawsuit Against Elanco Animal Health Incorporated (ELAN): The complaint alleges that the company minimized potential safety risks associated with Zenrelia, an oral Janus kinase ...